Improving Clinical Manufacturing of IL-15 Activated Cytokine-Induced Killer (CIK) Cells

Cytokine-induced killer (CIK) cells are an immunotherapeutic approach to combat relapse following allogeneic hematopoietic stem cell transplantation (HSCT) in acute leukemia or myelodysplastic syndrome (MDS) patients. Prompt and sequential administration of escalating cell doses improves the efficac...

Full description

Saved in:
Bibliographic Details
Published in:Front Immunol
Main Authors: Bremm, Melanie, Pfeffermann, Lisa-Marie, Cappel, Claudia, Katzki, Verena, Erben, Stephanie, Betz, Sibille, Quaiser, Andrea, Merker, Michael, Bonig, Halvard, Schmidt, Michael, Klingebiel, Thomas, Bader, Peter, Huenecke, Sabine, Rettinger, Eva
Format: Artigo
Language:Inglês
Published: Frontiers Media S.A. 2019
Subjects:
Immunology
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6554420/
https://ncbi.nlm.nih.gov/pubmed/31214182
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2019.01218
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items